img

Global Advanced Cell Therapies Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Advanced Cell Therapies Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Advanced cell-based therapies are promising approaches for stimulating full regeneration of cartilage lesions.
Advanced Cell Therapies report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Advanced Cell Therapies market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Stem Cell and Regenerative Medicine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Advanced Cell Therapies industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Advanced Cell Therapies key companies include FRC Blood Service, Fujifilm, Vericel, Advanced Cell Technology, Inc, Locate Bio Limited, Kolon TissueGene, Gamida Cell, Okyanos and Rexgenero, etc. FRC Blood Service, Fujifilm, Vericel are top 3 players and held % share in total in 2022.
Advanced Cell Therapies can be divided into Stem Cell Transplants and CAR T-cell Therapy, etc. Stem Cell Transplants is the mainstream product in the market, accounting for % share globally in 2022.
Advanced Cell Therapies is widely used in various fields, such as Stem Cell and Regenerative Medicine, etc. Stem Cell provides greatest supports to the Advanced Cell Therapies industry development. In 2022, global % share of Advanced Cell Therapies went into Stem Cell filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Advanced Cell Therapies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


FRC Blood Service
Fujifilm
Vericel
Advanced Cell Technology, Inc
Locate Bio Limited
Kolon TissueGene
Gamida Cell
Okyanos
Rexgenero
BioXcellerator
Takura
Autolus
Segment by Type
Stem Cell Transplants
CAR T-cell Therapy

Segment by Application


Stem Cell
Regenerative Medicine
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Advanced Cell Therapies market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Advanced Cell Therapies introduction, etc. Advanced Cell Therapies Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Advanced Cell Therapies market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Advanced Cell Therapies
1.1 Advanced Cell Therapies Market Overview
1.1.1 Advanced Cell Therapies Product Scope
1.1.2 Advanced Cell Therapies Market Status and Outlook
1.2 Global Advanced Cell Therapies Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Advanced Cell Therapies Market Size by Region (2018-2033)
1.4 Global Advanced Cell Therapies Historic Market Size by Region (2018-2023)
1.5 Global Advanced Cell Therapies Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Advanced Cell Therapies Market Size (2018-2033)
1.6.1 North America Advanced Cell Therapies Market Size (2018-2033)
1.6.2 Europe Advanced Cell Therapies Market Size (2018-2033)
1.6.3 Asia-Pacific Advanced Cell Therapies Market Size (2018-2033)
1.6.4 Latin America Advanced Cell Therapies Market Size (2018-2033)
1.6.5 Middle East & Africa Advanced Cell Therapies Market Size (2018-2033)
2 Advanced Cell Therapies Market by Type
2.1 Introduction
2.1.1 Stem Cell Transplants
2.1.2 CAR T-cell Therapy
2.2 Global Advanced Cell Therapies Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Advanced Cell Therapies Historic Market Size by Type (2018-2023)
2.2.2 Global Advanced Cell Therapies Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Advanced Cell Therapies Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Advanced Cell Therapies Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Advanced Cell Therapies Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Advanced Cell Therapies Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Advanced Cell Therapies Revenue Breakdown by Type (2018-2033)
3 Advanced Cell Therapies Market Overview by Application
3.1 Introduction
3.1.1 Stem Cell
3.1.2 Regenerative Medicine
3.2 Global Advanced Cell Therapies Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Advanced Cell Therapies Historic Market Size by Application (2018-2023)
3.2.2 Global Advanced Cell Therapies Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Advanced Cell Therapies Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Advanced Cell Therapies Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Advanced Cell Therapies Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Advanced Cell Therapies Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Advanced Cell Therapies Revenue Breakdown by Application (2018-2033)
4 Advanced Cell Therapies Competition Analysis by Players
4.1 Global Advanced Cell Therapies Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Advanced Cell Therapies as of 2022)
4.3 Date of Key Players Enter into Advanced Cell Therapies Market
4.4 Global Top Players Advanced Cell Therapies Headquarters and Area Served
4.5 Key Players Advanced Cell Therapies Product Solution and Service
4.6 Competitive Status
4.6.1 Advanced Cell Therapies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 FRC Blood Service
5.1.1 FRC Blood Service Profile
5.1.2 FRC Blood Service Main Business
5.1.3 FRC Blood Service Advanced Cell Therapies Products, Services and Solutions
5.1.4 FRC Blood Service Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.1.5 FRC Blood Service Recent Developments
5.2 Fujifilm
5.2.1 Fujifilm Profile
5.2.2 Fujifilm Main Business
5.2.3 Fujifilm Advanced Cell Therapies Products, Services and Solutions
5.2.4 Fujifilm Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.2.5 Fujifilm Recent Developments
5.3 Vericel
5.3.1 Vericel Profile
5.3.2 Vericel Main Business
5.3.3 Vericel Advanced Cell Therapies Products, Services and Solutions
5.3.4 Vericel Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.3.5 Advanced Cell Technology, Inc Recent Developments
5.4 Advanced Cell Technology, Inc
5.4.1 Advanced Cell Technology, Inc Profile
5.4.2 Advanced Cell Technology, Inc Main Business
5.4.3 Advanced Cell Technology, Inc Advanced Cell Therapies Products, Services and Solutions
5.4.4 Advanced Cell Technology, Inc Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.4.5 Advanced Cell Technology, Inc Recent Developments
5.5 Locate Bio Limited
5.5.1 Locate Bio Limited Profile
5.5.2 Locate Bio Limited Main Business
5.5.3 Locate Bio Limited Advanced Cell Therapies Products, Services and Solutions
5.5.4 Locate Bio Limited Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.5.5 Locate Bio Limited Recent Developments
5.6 Kolon TissueGene
5.6.1 Kolon TissueGene Profile
5.6.2 Kolon TissueGene Main Business
5.6.3 Kolon TissueGene Advanced Cell Therapies Products, Services and Solutions
5.6.4 Kolon TissueGene Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.6.5 Kolon TissueGene Recent Developments
5.7 Gamida Cell
5.7.1 Gamida Cell Profile
5.7.2 Gamida Cell Main Business
5.7.3 Gamida Cell Advanced Cell Therapies Products, Services and Solutions
5.7.4 Gamida Cell Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.7.5 Gamida Cell Recent Developments
5.8 Okyanos
5.8.1 Okyanos Profile
5.8.2 Okyanos Main Business
5.8.3 Okyanos Advanced Cell Therapies Products, Services and Solutions
5.8.4 Okyanos Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.8.5 Okyanos Recent Developments
5.9 Rexgenero
5.9.1 Rexgenero Profile
5.9.2 Rexgenero Main Business
5.9.3 Rexgenero Advanced Cell Therapies Products, Services and Solutions
5.9.4 Rexgenero Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.9.5 Rexgenero Recent Developments
5.10 BioXcellerator
5.10.1 BioXcellerator Profile
5.10.2 BioXcellerator Main Business
5.10.3 BioXcellerator Advanced Cell Therapies Products, Services and Solutions
5.10.4 BioXcellerator Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.10.5 BioXcellerator Recent Developments
5.11 Takura
5.11.1 Takura Profile
5.11.2 Takura Main Business
5.11.3 Takura Advanced Cell Therapies Products, Services and Solutions
5.11.4 Takura Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.11.5 Takura Recent Developments
5.12 Autolus
5.12.1 Autolus Profile
5.12.2 Autolus Main Business
5.12.3 Autolus Advanced Cell Therapies Products, Services and Solutions
5.12.4 Autolus Advanced Cell Therapies Revenue (US$ Million) & (2018-2023)
5.12.5 Autolus Recent Developments
6 North America
6.1 North America Advanced Cell Therapies Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Advanced Cell Therapies Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Advanced Cell Therapies Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Advanced Cell Therapies Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Advanced Cell Therapies Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Advanced Cell Therapies Market Dynamics
11.1 Advanced Cell Therapies Industry Trends
11.2 Advanced Cell Therapies Market Drivers
11.3 Advanced Cell Therapies Market Challenges
11.4 Advanced Cell Therapies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Advanced Cell Therapies Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Advanced Cell Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Advanced Cell Therapies Market Size Share by Region (2018-2023)
Table 4. Global Advanced Cell Therapies Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Advanced Cell Therapies Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Advanced Cell Therapies Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Advanced Cell Therapies Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Advanced Cell Therapies Revenue Market Share by Type (2018-2023)
Table 9. Global Advanced Cell Therapies Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Advanced Cell Therapies Revenue Market Share by Type (2024-2033)
Table 11. North America Advanced Cell Therapies Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Advanced Cell Therapies Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Advanced Cell Therapies Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Advanced Cell Therapies Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Advanced Cell Therapies Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Advanced Cell Therapies Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Advanced Cell Therapies Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Advanced Cell Therapies Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Advanced Cell Therapies Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Advanced Cell Therapies Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Advanced Cell Therapies Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Advanced Cell Therapies Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Advanced Cell Therapies Revenue Market Share by Application (2018-2023)
Table 24. Global Advanced Cell Therapies Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Advanced Cell Therapies Revenue Market Share by Application (2024-2033)
Table 26. North America Advanced Cell Therapies Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Advanced Cell Therapies Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Advanced Cell Therapies Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Advanced Cell Therapies Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Advanced Cell Therapies Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Advanced Cell Therapies Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Advanced Cell Therapies Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Advanced Cell Therapies Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Advanced Cell Therapies Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Advanced Cell Therapies Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Advanced Cell Therapies Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Advanced Cell Therapies Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Advanced Cell Therapies as of 2022)
Table 39. Date of Key Players Enter into Advanced Cell Therapies Market
Table 40. Global Advanced Cell Therapies Key Players Headquarters and Area Served
Table 41. Advanced Cell Therapies Product Solution and Service
Table 42. Global Advanced Cell Therapies Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. FRC Blood Service Basic Information List
Table 45. FRC Blood Service Description and Business Overview
Table 46. FRC Blood Service Advanced Cell Therapies Products, Services and Solutions
Table 47. Revenue (US$ Million) in Advanced Cell Therapies Business of FRC Blood Service (2018-2023)
Table 48. FRC Blood Service Recent Developments
Table 49. Fujifilm Basic Information List
Table 50. Fujifilm Description and Business Overview
Table 51. Fujifilm Advanced Cell Therapies Products, Services and Solutions
Table 52. Revenue (US$ Million) in Advanced Cell Therapies Business of Fujifilm (2018-2023)
Table 53. Fujifilm Recent Developments
Table 54. Vericel Basic Information List
Table 55. Vericel Description and Business Overview
Table 56. Vericel Advanced Cell Therapies Products, Services and Solutions
Table 57. Revenue (US$ Million) in Advanced Cell Therapies Business of Vericel (2018-2023)
Table 58. Vericel Recent Developments
Table 59. Advanced Cell Technology, Inc Basic Information List
Table 60. Advanced Cell Technology, Inc Description and Business Overview
Table 61. Advanced Cell Technology, Inc Advanced Cell Therapies Products, Services and Solutions
Table 62. Revenue (US$ Million) in Advanced Cell Therapies Business of Advanced Cell Technology, Inc (2018-2023)
Table 63. Advanced Cell Technology, Inc Recent Developments
Table 64. Locate Bio Limited Basic Information List
Table 65. Locate Bio Limited Description and Business Overview
Table 66. Locate Bio Limited Advanced Cell Therapies Products, Services and Solutions
Table 67. Revenue (US$ Million) in Advanced Cell Therapies Business of Locate Bio Limited (2018-2023)
Table 68. Locate Bio Limited Recent Developments
Table 69. Kolon TissueGene Basic Information List
Table 70. Kolon TissueGene Description and Business Overview
Table 71. Kolon TissueGene Advanced Cell Therapies Products, Services and Solutions
Table 72. Revenue (US$ Million) in Advanced Cell Therapies Business of Kolon TissueGene (2018-2023)
Table 73. Kolon TissueGene Recent Developments
Table 74. Gamida Cell Basic Information List
Table 75. Gamida Cell Description and Business Overview
Table 76. Gamida Cell Advanced Cell Therapies Products, Services and Solutions
Table 77. Revenue (US$ Million) in Advanced Cell Therapies Business of Gamida Cell (2018-2023)
Table 78. Gamida Cell Recent Developments
Table 79. Okyanos Basic Information List
Table 80. Okyanos Description and Business Overview
Table 81. Okyanos Advanced Cell Therapies Products, Services and Solutions
Table 82. Revenue (US$ Million) in Advanced Cell Therapies Business of Okyanos (2018-2023)
Table 83. Okyanos Recent Developments
Table 84. Rexgenero Basic Information List
Table 85. Rexgenero Description and Business Overview
Table 86. Rexgenero Advanced Cell Therapies Products, Services and Solutions
Table 87. Revenue (US$ Million) in Advanced Cell Therapies Business of Rexgenero (2018-2023)
Table 88. Rexgenero Recent Developments
Table 89. BioXcellerator Basic Information List
Table 90. BioXcellerator Description and Business Overview
Table 91. BioXcellerator Advanced Cell Therapies Products, Services and Solutions
Table 92. Revenue (US$ Million) in Advanced Cell Therapies Business of BioXcellerator (2018-2023)
Table 93. BioXcellerator Recent Developments
Table 94. Takura Basic Information List
Table 95. Takura Description and Business Overview
Table 96. Takura Advanced Cell Therapies Products, Services and Solutions
Table 97. Revenue (US$ Million) in Advanced Cell Therapies Business of Takura (2018-2023)
Table 98. Takura Recent Developments
Table 99. Autolus Basic Information List
Table 100. Autolus Description and Business Overview
Table 101. Autolus Advanced Cell Therapies Products, Services and Solutions
Table 102. Revenue (US$ Million) in Advanced Cell Therapies Business of Autolus (2018-2023)
Table 103. Autolus Recent Developments
Table 104. North America Advanced Cell Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 105. North America Advanced Cell Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 106. Europe Advanced Cell Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 107. Europe Advanced Cell Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 108. Asia-Pacific Advanced Cell Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 109. Asia-Pacific Advanced Cell Therapies Market Size by Region (2018-2023) & (US$ Million)
Table 110. Asia-Pacific Advanced Cell Therapies Market Size by Region (2024-2033) & (US$ Million)
Table 111. Asia-Pacific Advanced Cell Therapies Market Share by Region (2018-2023)
Table 112. Asia-Pacific Advanced Cell Therapies Market Share by Region (2024-2033)
Table 113. Latin America Advanced Cell Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 114. Latin America Advanced Cell Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 115. Latin America Advanced Cell Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 116. Middle East & Africa Advanced Cell Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 117. Middle East & Africa Advanced Cell Therapies Market Size by Country (2018-2023) & (US$ Million)
Table 118. Middle East & Africa Advanced Cell Therapies Market Size by Country (2024-2033) & (US$ Million)
Table 119. Advanced Cell Therapies Market Trends
Table 120. Advanced Cell Therapies Market Drivers
Table 121. Advanced Cell Therapies Market Challenges
Table 122. Advanced Cell Therapies Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Advanced Cell Therapies Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Advanced Cell Therapies Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Advanced Cell Therapies Market Share by Regions: 2022 VS 2033
Figure 4. Global Advanced Cell Therapies Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Advanced Cell Therapies Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Advanced Cell Therapies Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Advanced Cell Therapies Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Advanced Cell Therapies Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Advanced Cell Therapies Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Stem Cell Transplants
Figure 11. Global Stem Cell Transplants Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of CAR T-cell Therapy
Figure 13. Global CAR T-cell Therapy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Advanced Cell Therapies Market Size Share by Type: 2022 & 2033
Figure 15. North America Advanced Cell Therapies Revenue Market Share by Type (2018-2033)
Figure 16. Europe Advanced Cell Therapies Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Advanced Cell Therapies Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Advanced Cell Therapies Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Advanced Cell Therapies Revenue Market Share by Type (2018-2033)
Figure 20. Stem Cell Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Regenerative Medicine Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Global Advanced Cell Therapies Market Size Share by Application: 2022 & 2033
Figure 23. North America Advanced Cell Therapies Revenue Market Share by Application (2018-2033)
Figure 24. Europe Advanced Cell Therapies Revenue Market Share by Application (2018-2033)
Figure 25. Asia-Pacific Advanced Cell Therapies Revenue Market Share by Application (2018-2033)
Figure 26. Latin America Advanced Cell Therapies Revenue Market Share by Application (2018-2033)
Figure 27. Middle East and Africa Advanced Cell Therapies Revenue Market Share by Application (2018-2033)
Figure 28. Advanced Cell Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players Advanced Cell Therapies Market Share in 2022
Figure 30. North America Advanced Cell Therapies Market Share by Country (2018-2033)
Figure 31. United States Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 32. Canada Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 33. Germany Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 34. France Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 35. U.K. Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 36. Italy Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 37. Russia Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 38. Nordic Countries Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Advanced Cell Therapies Market Share by Region (2018-2033)
Figure 40. China Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 41. Japan Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 42. South Korea Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 44. India Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 45. Australia Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 46. Latin America Advanced Cell Therapies Market Share by Country (2018-2033)
Figure 47. Mexico Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 48. Brazil Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Advanced Cell Therapies Market Share by Country (2018-2033)
Figure 50. Turkey Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 52. UAE Advanced Cell Therapies Market Size (2018-2033) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report